Table 1.
Comparison of clinical characteristics between the Hp-eradicated and control groups before and after propensity-score matching.
| Clinical characteristics | All patients (n = 186) |
Propensity score-matched patients (n = 124) |
||||
|---|---|---|---|---|---|---|
| Hp-eradicated group n = 81 (%) |
Control group n = 105 (%) |
P value | Hp-eradicated group n = 62 (%) |
Control group n = 62 (%) |
P value | |
| Sex | 0.479 | 1.000 | ||||
| Male | 58 (71.6) | 80 (76.2) | 47 (75.8) | 47 (75.8) | ||
| Female | 23 (28.4) | 25 (23.8) | 15 (24.2) | 15 (24.2) | ||
| Age, yr | 61.81 ± 9.20 | 61.14 ± 8.90 | 0.616 | 60.97 ± 9.43 | 60.79 ± 9.09 | 0.915 |
| Age range | 0.863 | 0.719 | ||||
| ≤ 60 | 36 (44.4) | 48 (45.7) | 31 (50.0) | 29 (46.8) | ||
| >60 | 45 (55.6) | 57 (54.3) | 31 (50.0) | 33 (53.2) | ||
| Smoking history | 0.772 | 0.856 | ||||
| Yes | 33 (40.7) | 45 (42.9) | 27 (43.5) | 26 (41.9) | ||
| No | 48 (59.3) | 60 (57.1) | 35 (56.5) | 36 (58.1) | ||
| Drinking history | 0.771 | 1.000 | ||||
| Yes | 31 (38.3) | 38 (36.2) | 25 (40.3) | 25 (40.3) | ||
| No | 50 (61.7) | 67 (63.8) | 37 (59.7) | 37 (59.7) | ||
| Family history of GC | 0.284 | 0.717 | ||||
| Yes | 9 (11.1) | 7 (6.7) | 3 (4.8) | 5 (8.1) | ||
| No | 72 (88.9) | 98 (93.3) | 59 (95.2) | 57 (91.9) | ||
| CCI† | 0.93 ± 1.07 | 0.83 ± 1.03 | 0.531 | 0.85 ± 1.08 | 0.77 ± 0.97 | 0.663 |
| Number of clinical consultations | 3.98 ± 3.51 | 2.61 ± 2.31 | 0.003 | 3.81 ± 3.74 | 2.82 ± 2.46 | 0.086 |
| Number of endoscopic examinations | 1.98 ± 1.04 | 1.64 ± 0.95 | 0.022 | 1.82 ± 1.02 | 1.76 ± 0.80 | 0.696 |
| Clinical symptoms | 0.806 | 0.192 | ||||
| Abdominal pain | 22 (27.2) | 30 (28.6) | 20 (32.3) | 13 (21.0) | ||
| Bloating | 14 (17.3) | 14 (13.3) | 11 (17.7) | 8 (12.9) | ||
| Both pain and bloating | 10 (12.3) | 18 (17.1) | 6 (9.7) | 13 (21.0) | ||
| Others | 17 (21.0) | 18 (17.1) | 12 (19.3) | 9 (14.5) | ||
| None | 18 (22.2) | 25 (23.8) | 13 (21.0) | 19 (30.6) | ||
| Duration of symptoms (month) | 29.8 ± 61.37 | 17.3 ± 37.80 | 0.140 | 30.53 ± 68.13 | 14.16 ± 28.88 | 0.155 |
| Time of taking PPI† | <0.001 | <0.001 | ||||
| ≤ 1 year | 22 (27.2) | 83 (79.0) | 16 (25.8) | 47 (75.8) | ||
| >1 year | 59 (72.8) | 22 (21.0) | 46 (74.2) | 15 (24.2) | ||
†CCI: Charlson comorbidity index; PPI: proton pump inhibitor. Data are presented as the mean ± standard deviation or number (%).